Roberts Home Medical Oxygen Cylinders: CGMP Deviations Risk
Roberts Home Medical recalls oxygen refrigerated liquid cylinders with CGMP deviations. These products may have manufacturing issues affecting safety. Consumers should contact the company for details.
Recall notice
CGMP Deviations
Contact the company
What happened, in plain English
Roberts Home Medical is recalling oxygen refrigerated liquid cylinders that were manufactured with CGMP deviations. This means the product may not meet safety standards, potentially causing harm if used improperly. Read more at govinfonow.com/recall/39310-roberts-home-medical-oxygen-cylinders-cgmp-deviations-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39310-roberts-home-medical-oxygen-cylinders-cgmp-deviations-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1002-2019
Cite this page
“Roberts Home Medical Oxygen Cylinders: CGMP Deviations Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39310-roberts-home-medical-oxygen-cylinders-cgmp-deviations-risk. Based on FDA recall #D-1002-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1002-2019%22&limit=1).
Why it’s dangerous
CGMP deviations refer to manufacturing process failures that could lead to unsafe products. Oxygen refrigerated liquid cylinders are critical for medical use, so any deviation in production could affect safety and effectiveness.
Who’s affected
People who own or use oxygen refrigerated liquid cylinders from Roberts Home Medical in Rockville or Germantown, Maryland. Those with medical oxygen needs are most at risk.
How to tell if you have this one
Check for lot numbers: 01005100518, 01010101918, 01011101918, 01007112118, 01001100318, 01007072518, 01017120518, 01011090518, 01002100318. These cylinders were sold in Rockville or Germantown, Maryland.
- Brand
Roberts Home Medical- Category
Drug
What to do — step by step
Check Product Lot Number
Look for the specific lot numbers listed in the recall notice to confirm if your cylinder is affected.
Where it went and when
Where it was distributed
Distributed in D.C., Maryland and Virginia.
FDA distribution: “Product was distributed in MD, VA and the District of Columbia” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: District of Columbia, Maryland, Virginia.
Recall timeline
FDA terminated this recall 4 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is there a risk of serious injury?
The recall record does not describe the specific hazard severity, so it is unknown.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1002-2019 (December 19, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1002-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.